ZS Pharma, Inc. Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
ZS Pharma is a small to mid-sized biopharmaceutical company based in San Mateo, California, focused on developing therapies for conditions with limited treatment options. It relies on its ion-trap approach to create new medicines, with its lead product candidate seeking to treat hyperkalemia. Hyperkalemia, characterized by high serum potassium, can lead to serious renal complications and higher mortality risk in patients with chronic illnesses or those receiving RAAS inhibitors. Founded in 2008, ZS Pharma went public in 2014 and became part of the AstraZeneca Group in December 2015. Its development program targets therapies addressing ion imbalances for patients with serious illnesses.